Exploring marine organisms for new drug development
Integrative Multidisciplinary Discovery Platform to Unlock Marine Natural Products Therapeutic Opportunities
This study is exploring how special chemicals from ocean creatures like cyanobacteria and sponges can help find new medicines, with the hope of creating better treatments for different diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10891653 on NIH RePORTER |
What this research studies
This research focuses on harnessing the unique chemical properties of marine organisms, particularly cyanobacteria and sponges, to discover new therapeutic compounds. A collaborative team of experts will utilize advanced genomic and bioinformatics techniques to analyze the genetic material of these organisms, aiming to identify potential drug candidates. By leveraging cutting-edge artificial intelligence tools, the project seeks to unlock the biosynthetic potential of marine biodiversity, which may lead to innovative treatments for various diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with conditions that could be treated by novel drugs derived from marine sources.
Not a fit: Patients with conditions that are not addressed by the therapeutic compounds derived from marine organisms may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new medications derived from marine natural products, potentially improving treatment options for patients.
How similar studies have performed: Previous research has shown promise in discovering new drugs from marine organisms, indicating that this approach has potential for success.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Luesch, Hendrik — University of Florida
- Study coordinator: Luesch, Hendrik
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.